Involvement of oxidative stress in the accelerated formation of pentosidine in patients with end-stage renal failure

Nephrology

Volumn 4, Issue 5-6, 1998, Pages 407-412

  Cai, Zhe ^a,b   Shinzato, Toru ^a   Matsumoto, Yoshihiro ^a   Miwa, Masamiki ^a   Otani, Hiroko ^a   Nakai, Shigeru ^a   Usami, Jun ^a   Oka, Hirobumi ^a   Takai, Ichiro ^a   Maeda, Kenji ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b NONE   (United States)

Author keywords

Oxidative stress; Pentosidine; Renal failure

Indexed keywords

PENTOSIDINE;

ADULT; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032454638     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1998.tb00380.x     Document Type: Article

References (37)

1. 1. Skolnik EY, Yang Z, Makita Z et al. Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy. J. Exp. Med. 1991; 174: 931-9.
2. 2. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 1988; 318: 1315-21.
3. 3. Miyata T, Ueda Y, Shinzato T et al. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: Renal implications in the pathophysiology of pentosidine. J. Am. Soc. Nephrol. 1996; 7: 1198-206.
4. 4. Miyata T, Hori O, Zhang J et al. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-β2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: Implications for the pathogenesis of dialysis-related amyloidosis. J. Clin. Jnvest. 1996; 98: 1088-94.
5. 5. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc. Natl Acad. Sci. USA 1990; 87: 9010-14.
6. 6. Wautier JL, Wautier MP, Schmidt AM et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications. Proc. Natl Acad. Sci. USA 1994; 91: 7742-6.
7. 7. Miyata T, Inagi R, Iida Y et al. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J. Clin. Invest. 1994; 93: 521-8.
8. 8. Iida Y, Miyata T, Inagi R, Sugiyama S, Maeda K. β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem.. Biophys. Res. Commun. 1994; 201: 1235-41.
9. 9. Miyata T, Iida Y, Ueda Y et al. Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products. Kidney Int. 1996; 49: 538-50.
10. 10. Miyata T, Oda O, Inagi R et al. β2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J. Clin. Invest. 1993; 92: 1243-52.
11. 11. Miyata T, Inagi R, Wada Y et al. Glycation of human β2-microglobulin in patients with hemodialysis-associated amyloidosis: Identification of the glycated sites. Biochemistry 1994; 33: 12215-21.
12. 12. Miyata T, Taneda S, Kawai R et al. Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc. Natl Acad. Sci. USA 1996; 93: 2353-8.
13. 13. Smith MA, Taneda S, Richey PL et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl Acad. Sci. USA 1994; 91: 5710-14.
14. 14. Yan SD, Yan EF, Chen X et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nature Med. 1995; 1: 693-9.
15. 15. Monnier VM, Sell DR, Nagaraj RH et al. Maillard reaction-mediated molecular damage to extracellullar matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 1992; 41 (Suppl. 2): 36-41.
16. 16. Odetti P, Forgarty J, Sell DR, Monnier VM. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992; 41: 153-9.
17. 17. Taneda S, Monnier VM. Enzyme-linked immunosorbent assay (ELISA) for pentosidine, an advanced glycation end product in biological specimens. Clin. Chem. 1994; 40: 1766-73.
18. 18. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. J. Biol. Chem. 1989; 264: 21597-602.
19. 19. Sell DR, Lapolla A, Odetti P, Forgarty J, Monnier VM. Pentosidine formation in skin correlates with severity of complications in individuals with long standing IDDM. Diabetes 1992; 41: 1286-92.
20. 20. Friedlander MA, Wu YC, Schulak JA, Monnier VM, Hricik DE. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am. J. Kidney Dis. 1995; 25: 445-51.
21. 21. Baynes JW. Perspectives in diabetes. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
22. 22. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW. Formation of penrosidine during nonenzymatic browning of protein by glucose: Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. Biol. Chem. 1991; 266: 11654-60.
23. 23. Wolff SP, Dean RT. Glucose autoxidation and protein modification. The poteintial role of 'autoxidative glycosylation' in diabetes. Biochem. J. 1987; 245: 243-50.
24. 24. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation: Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochem. J. 1988; 256: 205-12.
25. 25. Ichikawa I, Kiyama S, Yoshioka T. Renal antioxidant enzymes: Their regulation and function. Kidney Int. 1994; 45: 1-9.
26. 26. McGrath LT, Douglas AF, McClean E et al. Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis. Clin. Chim. Acta 1995; 235: 179-88.
27. 27. Loughrey CM, Young IS, Kightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in hemodialysis. Q. J. Med. 1994; 87: 679-83.
28. 28. Paul JL, Sall ND, Soni T et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993; 64: 106-9.
29. 29. Haklar G, Yegenaga I, Yalcin AS. Evaluation of oxidant stress in chronic hemodialysis patients: use of different parameters. Clin. Chim. Acta 1995; 234: 109-14.
30. 30. Witko-Sasat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996; 49: 1304-13.
31. 31. Takahashi K, Cohen HJ. Selenium-dependent glutathione peroxidase protein and activity: Immunological investigation on cellular and plasma enzymes. Blood 1986; 68: 640-5.
32. 32. Cai Z, Miyata T, Horie K, Iida Y, Maeda K. β2-Microglobulin modified with advanced glycation end products induces monocyte chemotaxis in vivo. Nephrol. Dial. Transplant. 1996; 11: 1189-91.
33. 33. Miyata T, Iida Y, Horie K, Cai Z, Maeda K. Pathophysiology of advanced glycation end products in renal failure. Nephrol. Dial. Transplant. 1996; 11 (Suppl. 5): 27-30.
34. 34. Miyata T, Wada Y, Cai Z et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 1997; 51:1170-81.
35. 35. Canestrari F, Galli F, Giorgini A et al. Erythrocyte redox state in uremic anemia: Effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol. 1994; 91: 187-93.
36. 36. Schiavon R, Biasioli S, De Fanti E et al. The plasma glutathione peroxidase enzyme in hemodialysis subjects. ASAIO J. 1994; 40: 968-71.
37. 37. Yamamoto Y, Takekoshi Y, Itami N et al. Enzyme-linked immunoscorbent assay for extracellular glutathione peroxidase in the serum of normal individals and patients with renal failure on hemodialysis. Clin. Chem. Acta 1995; 236: 93-9.